Gene expression profiles of hepatoma cell line HLE

World Journal of Gastroenterology

Volumn 9, Issue 4, 2003, Pages 683-687

  Liu, Lian Xin ^a,b   Liu, Zhi Hua ^b   Jiang, Hong Chi ^b   Zhang, Wei Hui ^a   Qi, Shu Yi ^a   Hu, Jie ^a   Wang, Xiu Qin ^b   Wu, Min ^b  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF CANCER RESEARCH   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA RHO GUANOSINE DIPHOSPHATE DISSOCIATION INHIBITOR ALPHA; BETA7 INTEGRIN; BETA8 INTEGRIN; CARTILAGE SPECIFIC PROTEOGLYCAN CORE PROTEIN; COMPLEMENTARY DNA; CYCLIN C; CYTOKERATIN 4; DNA PROTEIN KINASE; DNA TOPOISOMERASE; EPIDERMAL GROWTH FACTOR RECEPTOR PATHWAY SUBSTRATE 15; INTERSTITIAL PROTEOGLYCAN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 6; MITOGEN ACTIVATED PROTEIN KINASE 7; PROTEIN; PROTEIN KINASE B 1; TENACEIN R; TERATOCARCINOMA DERIVED GROWTH FACTOR 1; TRANSCRIPTION FACTOR E2F DIMERIZATION FACTOR 2; TRANSCRIPTION FACTOR E2F3; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATLAS; CANCER CELL CULTURE; CANCER GENETICS; CANCER GROWTH; CELL GROWTH; CELL PROLIFERATION; COMPUTER PROGRAM; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DOWN REGULATION; GENE ACTIVATION; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENETIC LINKAGE; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; NORTHERN BLOTTING; OUTCOMES RESEARCH; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UPREGULATION;

EID: 0038639160     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i4.683     Document Type: Article

References (38)

1. Schafer DF, Sorrell MF. Hepatocellular carcinoma. Lancet 1999; 353: 1253-1257
2. Qin LX, Tang ZY. The prognostic molecular markers in hepatocellular carcinoma. World J Gastroenterol 2002; 8: 385-392
3. Wu W, Lin XB, Qian JM, Ji ZL, Jiang Z. Ultrasonic aspiration hepatectomy for 136 patients with hepatocellular carcinoma. World J Gastroenterol 2002; 8: 763-765
4. Tang ZY, Sun FX, Tian J, Ye SL, Liu YK, Liu KD, Xue Q, Chen J, Xia JL, Qin LX, Sun SL, Wang L, Zhou J, Li Y, Ma ZC, Zhou XD, Wu ZQ, Lin ZY, Yang BH. Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential. World J Gastroenterol 2001; 7: 597-601
5. Liu LX, Jiang HC, Piao DX. Radiofrequence ablation of liver cancers. World J Gastroenterol 2002; 8: 393-399
6. Rabe C, Pilz T, Klostermann C, Berna M, Schild HH, Sauerbruch T, Caselmann WH. Clinical characteristics and outcome of a cohort of 101 patients with hepatocellular carcinoma. World J Gastroenterol 2001; 7: 208-215
7. Tang ZY. Hepatocellular carcinoma-cause, treatment and metastasis. World J Gastroenterol 2001; 7: 445-454
8. Zhao WH, Ma ZM, Zhou XR, Feng YZ, Fang BS. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score. World J Gastroenterol 2002; 8: 237-242
9. Jiang HC, Liu LX, Piao DX, Xu J, Zheng M, Zhu AL, Qi SY, Zhang WH, Wu LF. Clinical short-term results of radiofrequency ablation in liver cancers. World J Gastroenterol 2002; 8: 624-630
10. Yip D, Findlay M, Boyer M, Tattersall MH. Hepatocellular carcinoma in central Sydney: A 10-year review of patients seen in a medical oncology department. World J Gastroenterol 1999; 5: 483-487
11. Chen MS, Li JQ, Zhang YQ, Lu LX, Zhang WZ, Yuan YF, Guo YP, Lin XJ, Li GH. High-dose iodized oil transcathether arterial chemoembolization for patients with large hepatocellular carcinoma. World J Gastroenterol 2002; 8: 74-78
12. Zhang WH, Zhu SN, Lu SL, Huang YL, Zhao P. Three-dimensional image of hepatocellular carcinoma under confocal laser scanning microscope. World J Gastroenterol 2000; 6: 344-347
13. Jiang YF, Yang ZH, Hu JQ. Recurrence or metastasis of HCC: Predictors, early detection and experimental antiangiogenic therapy. World J Gastroenterol 2000; 6: 61-65
14. Sithinamsuwan P, Piratvisuth T, Tanomkiat W, Apakupakul N, Tongyoo S. Review of 336 patients with hepatocellular carcinoma at Songklanagarind Hospital. World J Gastroenterol 2000; 6: 339-343
15. Fan J, Wu ZQ, Tang ZY, Zhou J, Qiu SJ, Ma ZC, Zhou XD, Ye SL. Multimodality treatment in hepatocellular carcinoma patients with tumor thrombi in portal vein. World J Gastroenterol 2001; 7: 28-32
16. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 1995; 270: 467-470
17. DeRisi J, Penland L, Brown PO, Bittner ML, Meltzer PS, Ray M, Chen Y, Su YA, Trent JM. Use of a cDNA microarray to analyse gene expression patterns in human cancer. Nat Genet 1996; 14: 457-460
18. Liu LX, Liu ZH, Jiang HC, Qu X, Zhang WH, Wu LF, Zhu AL, Wang XQ, Wu M. Profiling of differentially expressed genes in human gastric carcinoma by cDNA expression array. World J Gastroenterol 2002; 8: 580-585
19. Wang K, Gan L, Jeffery E, Gayle M, Gown AM, Skelly M, Nelson PS, Ng WV, Schummer M, Hood L, Mullligan J. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray. Gene 1999; 229: 101-108
20. Ross DT, Scherf U, Eisen MB, Perou CM, Rees C, Spellman P, Iyer V, Jeffrey SS, Van De Rijn M, Waltham M, Pergamenschikov A, Lee JC, Lashkari D, Shalon D, Myers TG, Weinstein JN, Botstein D, Brown PO. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet 2000; 24: 227-235
21. Khan J, Simon R, Bittner M, Chen Y, Leighton SB, Pohida T, Smith PD, Jiang Y, Gooden GC, Trent JM, Meltzer PS. Gene expression profiling of alveolar rhabdomyosarcoma with cDNA microarrays. Cancer Res 1998; 58: 5009-5013
22. Lu J, Liu Z, Xiong M, Wang Q, Wang X, Yang G, Zhao L, Qiu Z, Zhou C, Wu M. Gene expression profile changes in initiation and progression of squamous cell carcinoma of esophagus. Int J Cancer 2001; 91: 288-294
23. Kallioniemi OP. Biochip technologies in cancer research. Ann Med 2001; 33: 142-147
24. Liu LX, Jiang HC, Liu ZH, Zhou J, Zhang WH, Zhu AL, Wang XQ, Wu M. Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol 2002; 8: 631-637
25. Khan J, Saal LH, Bittner ML, Chen Y, Trent JM, Meltzer PS. Expression profiling in cancer using cDNA microarrays. Electrophoresis 1999; 20: 223-229
26. Hu YC, Lam KY, Law S, Wong J, Srivastava G. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: Overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 2001; 7: 2213-2221
27. Selaru FM, Zou T, Xu Y, Shustova V, Yin J, Mori Y, Sato F, Wang S, Olaru A, Shibata D, Greenwald BD, Krasna MJ, Abraham JM, Meltzer SJ. Global gene expression profiling in Barrett's esophagus and esophageal cancer: A comparative analysis using cDNA microarrays. Oncogene 2002; 21: 475-478
28. Leone G, DeGregori J, Yan Z, Jakoi L, Ishida S, Williams RS, Nevins JR. E2F3 activity is regulated during the cell cycle and is required for the induction of S phase. Genes Dev 1998; 12: 2120-2130
29. Moberg K, Starz MA, Lees JA. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol Cell Biol 1996; 16: 1436-1449
30. Zhang Y, Chellappan SP. Cloning and characterization of human DP2, a novel dimerization partner of E2F. Oncogene 1995; 10: 2085-2093
31. Zhang Y, Venkatraj VS, Fischer SG, Warburton D, Chellappan SP. Genomic cloning and chromosomal assignment of the E2F dimerization partner TFDP gene family. Genomics 1997; 39: 95-98
32. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998; 10: 10262-10267
33. Alessi DR, Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 1998; 8: 55-62
34. Jackson SP. DNA-dependent protein kinase. Int J Biochem Cell Biol 1997; 29: 935-938
35. Lee SE, Mitchell RA, Cheng A, Hendrickson EA. Evidence for DNA-PK-dependent and -independent DNA double-strand break repair pathways in mammalian cells as a function of the cell cycle. Mol Cell Biol 1997; 17: 1425-1433
36. Denda S, Reichardt LF, Muller U. Identification of osteopontin as a novel ligand for the integrin alpha8 beta1 and potential roles for this integrin-ligand interaction in kidney morphogenesis. Mol Biol Cell 1998; 9: 1425-1435
37. Denda S, Muller U, Crossin KL, Erickson HP, Reichardt LF. Utilization of a soluble integrin-alkaline phosphatase chimera to characterize integrin alpha 8 beta 1 receptor interactions with tenascin: Murine alpha 8 beta 1 binds to the RGD site in tenascin-C fragments, but not to native tenascin-C. Biochemistry 1998; 37: 5464-5474
38. Fogerty FJ, Akiyama SK, Yamada KM, Mosher DF. Inhibition of binding of fibronectin to matrix assembly sites by anti-integrin (alpha 5 beta 1) antibodies. J Cell Biol 1990; 111: 699-708